220 related articles for article (PubMed ID: 9933846)
1. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
Takei K; Ito H; Masai M; Kotake T
Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
[TBL] [Abstract][Full Text] [Related]
2. Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid.
Lindsjö M; Fellström B; Ljunghall S; Wikström B; Danielson BG
Lancet; 1989 Sep; 2(8665):701-4. PubMed ID: 2570957
[TBL] [Abstract][Full Text] [Related]
3. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
4. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
Jaeger P; Portmann L; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
[TBL] [Abstract][Full Text] [Related]
5. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
6. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
Mitwalli A; Ayiomamitis A; Grass L; Oreopoulos DG
Int Urol Nephrol; 1988; 20(4):353-9. PubMed ID: 3170105
[TBL] [Abstract][Full Text] [Related]
7. ALLN-177, oral enzyme therapy for hyperoxaluria.
Lingeman JE; Pareek G; Easter L; Pease R; Grujic D; Brettman L; Langman CB
Int Urol Nephrol; 2019 Apr; 51(4):601-608. PubMed ID: 30783888
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
Espino-Grosso P; Monsour C; Canales BK
Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
10. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
Baggio B; Gambaro G; Favaro S; Borsatti A
Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
[TBL] [Abstract][Full Text] [Related]
12. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
Yendt ER; Cohanim M
Clin Invest Med; 1986; 9(1):44-50. PubMed ID: 3955921
[TBL] [Abstract][Full Text] [Related]
13. A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
Langman CB; Grujic D; Pease RM; Easter L; Nezzer J; Margolin A; Brettman L
Am J Nephrol; 2016; 44(2):150-8. PubMed ID: 27529510
[TBL] [Abstract][Full Text] [Related]
14. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
15. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
[TBL] [Abstract][Full Text] [Related]
16. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
[TBL] [Abstract][Full Text] [Related]
17. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
[TBL] [Abstract][Full Text] [Related]
19. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
Hatch M
Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
[TBL] [Abstract][Full Text] [Related]
20. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
D'Costa MR; Kausz AT; Carroll KJ; Ingimarsson JP; Enders FT; Mara KC; Mehta RA; Lieske JC
Nephrol Dial Transplant; 2021 Dec; 36(12):2208-2215. PubMed ID: 33367720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
